Clorox (NYSE:CLX) Announces FY 2027 Earnings Guidance

Clorox (NYSE:CLX) issued an update on its FY 2027 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 5.700-6.000 for the period, compared to the consensus estimate of 5.690. The company issued revenue guidance of $7.6 billion-$7.7 billion, compared to the consensus revenue estimate of $7.6 billion.

Clorox Trading Up 4.3%

NYSE:CLX opened at $93.77 on Wednesday. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The company has a market capitalization of $11.34 billion, a P/E ratio of 16.87, a P/E/G ratio of 3.00 and a beta of 0.59. The stock’s 50 day moving average price is $88.00 and its 200 day moving average price is $99.83. Clorox has a 52 week low of $79.12 and a 52 week high of $128.90.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.48. The firm had revenue of $1.91 billion during the quarter, compared to analysts’ expectations of $1.88 billion. Clorox had a net margin of 9.41% and a return on equity of 601.88%. Clorox’s revenue for the quarter was up 33.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.85 earnings per share. On average, research analysts forecast that Clorox will post 5.68 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 5.3%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio is currently 103.73%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. TD Cowen reissued a “hold” rating on shares of Clorox in a research report on Tuesday. The Goldman Sachs Group restated a “sell” rating and set a $74.00 target price on shares of Clorox in a research note on Tuesday. Wells Fargo & Company lifted their price target on Clorox from $85.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, October 3rd. Finally, Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 29th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $93.29.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox reported adjusted earnings of $1.55 per share, above the $1.07 consensus, and revenue of $1.91 billion, ahead of estimates. Sales rose 33.3% year over year; cost savings and contributions from GOJO helped support results. The company also kept its fiscal 2027 adjusted EPS guidance at $5.70–$6.00, with revenue guidance of $7.6 billion–$7.7 billion. Clorox Shares Rally After Q1 Earnings Beat
• Positive Sentiment: Evercore raised its rating from Underperform to In Line, citing the new CEO’s turnaround experience, and set a $99 price target. This offers a more constructive view after prior bearish coverage. Evercore on Clorox’s new CEO
• Neutral Sentiment: Analyst reactions were mixed: UBS raised its target to $96 but maintained Neutral, while JPMorgan raised its target to $86 and retained an Underweight rating. UBS adjusts Clorox price target
• Negative Sentiment: Rising input costs are squeezing margins, and Clorox expects adjusted earnings near the low end of its full-year range. The company is relying on pricing, productivity improvements and GOJO integration savings to offset cost pressure. Clorox trims outlook on higher costs
• Negative Sentiment: The GOJO acquisition has increased Clorox’s debt burden, raising questions among some investors about financial flexibility and dividend safety if costs remain elevated. Clorox earnings outlook and dividend concerns

About Clorox

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.